Retatrutide is still being studied in clinical trials and is not the same as fully approved commercial products
We understand that various factors, including the use of prescription medications like Semaglutide GLP-1 can influence weight loss
Acta Physiol (Oxf) (2011) 201(1):1516
The science behind why triple receptor activation changes appetite differently Understanding the neuroscience helps explain why retatrutide appetite suppression feels qualitatively different from single-receptor medications
Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Retatrutide targets GLP-1 and GIP hormones too, but it also mimics the glucagon hormone